Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
SPRUCE BIOSCIENCES, INC. terminated Lease Termination Agreement with BP3-SF7 2001 JS OWNER LLC valued at a termination fee of $0.6 million (effective 2022-11-28).
- Action
- termination
- Agreement
- lease
- Counterparty
- BP3-SF7 2001 JS OWNER LLC
- Value
- a termination fee of $0.6 million
- Effective
- 2022-11-28
Exact text from the filing
On November 28, 2022, the Company entered into a Lease Termination Agreement (the “Lease Termination Agreement”) with BP3-SF7 2001 JS OWNER LLC (the “Landlord”) to terminate that certain Office Lease Agreement, dated as of February 13, 2020, by and between the Company and the Landlord (as successor-in-interest to DC Station Owner, LLC) (the “Prior Lease”) for certain premises located at 2001 Junipero Serra Boulevard, Suite 640, Daily City, California 94014.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
SPRUCE BIOSCIENCES, INC. entered into New Lease with 611 Gateway Center LP valued at approximately $0.3 million (effective 2022-12-01).
- Action
- entry
- Agreement
- lease
- Counterparty
- 611 Gateway Center LP
- Value
- approximately $0.3 million
- Effective
- 2022-12-01
Exact text from the filing
On December 1, 2022, Spruce Biosciences, Inc. (the “Company”) entered into a lease agreement (the “New Lease”) with 611 Gateway Center LP for the lease of 6,496 square feet of office space located at 611 Gateway Boulevard, Suite 740, South San Francisco, California 94080, for the Company’s principal executive offices.
View on SEC.gov